{"schema_version":"alpha-profile-public-v1","slug":"athena-countouriotis","canonical_url":"https://registry.alpha.ac/people/athena-countouriotis","as_of":"2026-09-21T18:55:49.529665+00:00","published_at":"2026-09-02T02:37:25.097762+00:00","last_reviewed_at":"2026-05-07T00:25:15.745+00:00","identity":{"display_name":"Athena Countouriotis","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"BIOMARIN PHARMACEUTICAL INC","company_slug":"biomarin-pharmaceutical-inc","exchange":"NASDAQ","ticker":"BMRN","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2023-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","effective_date":"2026-04-21","last_checked_at":"2026-05-07T00:23:06.905+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=athena-countouriotis","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=athena-countouriotis&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Athena Countouriotis, M.D. is co-founder, President, CEO and Chairperson of Avenzo Therapeutics since October 2022, and previously served as President and CEO of Turning Point Therapeutics, leading it through its IPO and acquisition by Bristol Myers Squibb. She has also held Chief Medical Officer roles at Adverum Biotechnologies, Halozyme Therapeutics, and Ambit Biosciences, and earlier held clinical development roles at Pfizer and Bristol-Myers Squibb."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"BIOMARIN PHARMACEUTICAL INC","organizationId":"biomarin-pharmaceutical-inc","title":"Director","period":"2023-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"BIOMARIN PHARMACEUTICAL INC","company_slug":"biomarin-pharmaceutical-inc","exchange":"NASDAQ","ticker":"BMRN","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2023-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","effective_date":"2026-04-21","last_checked_at":"2026-05-07T00:23:06.905+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Athena Countouriotis as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-07T00:25:16.032794+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BMRN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","published_at":"2026-04-21T00:00:00+00:00","last_checked_at":"2026-05-07T00:25:15.860541+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Athena Countouriotis currently serves as Director at BioMarin Pharmaceutical.","claim_state":"verified","valid_from":"2026-04-21","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-07T00:25:15.98088+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BMRN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","published_at":"2026-04-21T00:00:00+00:00","last_checked_at":"2026-05-07T00:25:15.860541+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Science/Innovation","Transactions and Strategy"],"claim_text":"Athena Countouriotis serves on Science/Innovation, Transactions and Strategy.","claim_state":"verified","valid_from":"2026-04-21","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-07T00:25:16.006089+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BMRN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","published_at":"2026-04-21T00:00:00+00:00","last_checked_at":"2026-05-07T00:25:15.860541+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Avenzo Therapeutics","claim_text":"Athena Countouriotis is linked to Avenzo Therapeutics as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-07T00:25:16.194221+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BMRN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","published_at":"2026-04-21T00:00:00+00:00","last_checked_at":"2026-05-07T00:25:15.860541+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Co-founder, President, Chief Executive Officer and Chairperson","claim_text":"Athena Countouriotis is also listed as Co-founder, President, Chief Executive Officer and Chairperson.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-07T00:25:16.165736+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BMRN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","published_at":"2026-04-21T00:00:00+00:00","last_checked_at":"2026-05-07T00:25:15.860541+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Athena Countouriotis as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-07T00:25:16.08892+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BMRN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","published_at":"2026-04-21T00:00:00+00:00","last_checked_at":"2026-05-07T00:25:15.860541+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Athena Countouriotis as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-07T00:25:16.059151+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"BMRN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","published_at":"2026-04-21T00:00:00+00:00","last_checked_at":"2026-05-07T00:25:15.860541+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:athena-countouriotis","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2023-01-01 · current","organization":"BIOMARIN PHARMACEUTICAL INC","organization_id":"biomarin-pharmaceutical-inc"},"claim_text":"Director at BIOMARIN PHARMACEUTICAL INC (2023-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/athena-countouriotis#profile","url":"https://registry.alpha.ac/people/athena-countouriotis","dateModified":"2026-05-07T00:25:15.745+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/athena-countouriotis#person","name":"Athena Countouriotis","url":"https://registry.alpha.ac/people/athena-countouriotis","jobTitle":"Director","worksFor":{"@type":"Organization","name":"BIOMARIN PHARMACEUTICAL INC","tickerSymbol":"NASDAQ: BMRN"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2023-01-01","memberOf":{"@type":"Organization","name":"BIOMARIN PHARMACEUTICAL INC","url":"https://registry.alpha.ac/companies/biomarin-pharmaceutical-inc","tickerSymbol":"NASDAQ: BMRN"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","name":"BMRN DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/athena-countouriotis"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-07T00:25:15.745+00:00","observed_at":"2026-09-21T18:55:49.529665+00:00","freshness_days":138}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"athena-countouriotis","canonical_url":"https://registry.alpha.ac/people/athena-countouriotis"},"publication":{"published_at":"2026-09-02T02:37:25.097762+00:00","last_reviewed_at":"2026-05-07T00:25:15.745+00:00","as_of":"2026-09-21T18:55:49.529665+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/athena-countouriotis","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/athena-countouriotis","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/athena-countouriotis.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}